10x Genomics, Inc.

TXG

—

Advanced chart & tools →

10x Genomics, Inc.TXG

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.35

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$642.82M

Net income

$-43.54M

Net margin

-6.8%

Gross margin

69.1%

Dividends & financials

10x Genomics, Inc. (TXG) reported revenue of $642.82M and net income of $-43.54M, or $-0.35 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.